Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
4 Patents
#169 in South San Francisco, CA
#14,063 in California
#60,704 in US
Amphivena Therapeutics, Inc.
Forward Citations = 18
15 inventors:
South San Francisco, CA, United States of America
Amphivena Therapeutics, Inc.
Calculating rank
EPO Patents = 1
Forward Citations = 18
Loading Chart...
Loading Chart...
15 inventors (with patents filed for the assignee):
Luke Evnin (4 out of 24 patents)
Jeanmarie Guenot (4 out of 17 patents)
Lori Kunkel (4 out of 7 patents)
4. Kristina Ellwanger (3 out of 11 patents)
5. Michael Weichel (3 out of 7 patents)
6. Uwe Reusch (3 out of 19 patents)
7. Stefan Knackmuss (3 out of 15 patents)
8. Judith A Fox (3 out of 7 patents)
9. Ivica Fucek (3 out of 11 patents)
10. Vera Molkenthin (3 out of 5 patents)
11. Erich Rajkovic (3 out of 10 patents)
12. Claudia Wall (3 out of 3 patents)
13. Eugene Zhukovsky (3 out of 5 patents)
14. Melvyn Little (3 out of 23 patents)
15. Vera Molkenthin (1 patent)
4 patents:
Company Overview
Amphivena Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative immunotherapies for the treatment of cancer. The company is dedicated to advancing novel therapies that harness the power of the immune system to target and eliminate cancer cells. Amphivena's pipeline includes promising candidates designed to enhance the body's natural immune response to cancer, offering new hope to patients facing difficult-to-treat malignancies.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amphivena Therapeutics, Inc.. Retrieved from https://idiyas.com/company/amphivena-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]